Safety Considerations for the Implementation of Subcutaneous Rituximab Formulationenglish
Version: 1 Jun 2018
Type of Content: Drug Safety, Guidelines & Advice, Clinical
Document Status: Current
The Systemic Treatment Program would like to raise awareness of potential safety concerns and mitigation strategies shared by provinces who have adopted the subcutaneous rituximab formulation.
Intended Guideline Users
Providers (Physicians, Pharmacists, Nurses)
Full Report (PDF) (342.98 KB)